...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Characterization of a genetically engineered inactivation- resistant coagulation factor VIIIa
【24h】

Characterization of a genetically engineered inactivation- resistant coagulation factor VIIIa

机译:基因工程抗失活凝血因子VIIIa的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Individuals with hemophilia A require fre- quent infusion of preparations of coagulation factor VIII. The activity of factor VIII (FVIII) as a cofactor for factor IXa in the coagulation cascade is limited by its instability after activation by thrombin. Activation of FVIII occurs through proteolytic cleav- age and generates an unstable FVIII heterotrimer that is subject to rapid dissociation of its subunits. In addition, further proteo- lytic cleavage by thrombin, factor Xa, factor IXa, and activated protein C can lead to inactivation. We have engineered and characterized a FVIII protein, IR8, that has enhanced in vitro stability of FVIII activity due to resistance to subunit dissociation and proteolytic inactivation.
机译:患有A型血友病的患者需要经常输注凝血因子VIII的制剂。在凝血级联反应中,凝血因子VIII(FVIII)作为凝血因子IXa的辅助因子的活性受到其不稳定性的限制。 FVIII的活化通过蛋白水解切割发生,并产生不稳定的FVIII异源三聚体,该异源三聚体会快速分解其亚基。另外,凝血酶,Xa因子,IXa因子和活化的蛋白C进一步的蛋白水解切割可能导致失活。我们已经设计并鉴定了一种FVIII蛋白IR8,由于对亚基解离和蛋白水解失活具有抗性,因此具有增强的FVIII活性体外稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号